SCHEMBL2128015

SCHEMBL2128015

O=C(O)c1ccc(NCc2cnc(NC(=O)N(C3CCCCC3)C3CCCCC3)s2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TP53 P04637 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LCK P06239 1/20 0.39
JAK3 P52333 1/20 0.39
KDR P35968 3/20 0.39
MAPT P10636 3/20 0.38
MAPK1 P28482 1/20 0.38
OGA O60502 1/20 0.38
NPSR1 Q6W5P4 2/20 0.37
HDAC3 O15379 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC6 Q9UBN7 1/20 0.37
CCNE1 P24864 3/20 0.37
CDK2 P24941 3/20 0.37
CDK5 Q00535 3/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1000367 0.89 MEN1 (0.48) NPC1RAB9ASMN1; SMN2MAPTMAPK1
SCHEMBL998937 0.81 ALDH1A1 (0.44) NPC1RAB9ASMN1; SMN2TP53L3MBTL1
SCHEMBL1002667 0.80 SMN1; SMN2 (0.40) NPC1RAB9ASMN1; SMN2TP53L3MBTL1
SCHEMBL1000697 0.79 OGA (0.43) NPC1RAB9ASMN1; SMN2TP53L3MBTL1
SCHEMBL1000146 0.79 CNR1 (0.47) NPC1RAB9ASMN1; SMN2TP53L3MBTL1
SCHEMBL12314933 0.79 SMN1; SMN2 (0.42) NPC1RAB9ASMN1; SMN2TP53L3MBTL1
SCHEMBL1002094 0.79 SMN1; SMN2 (0.42) NPC1RAB9ASMN1; SMN2TP53L3MBTL1
SCHEMBL998918 0.78 OGA (0.40) NPC1RAB9ASMN1; SMN2TP53L3MBTL1
SCHEMBL1000355 0.77 SMN1; SMN2 (0.42) NPC1RAB9ASMN1; SMN2TP53L3MBTL1
SCHEMBL2606414 0.77 ITK (0.38) LCKJAK3NPSR1CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2444397-A1 Heteroaryl-ureas and their use as glucokinase activators Novo Nordisk A/S (DK) 2012-04-25 EP disclosed